CA2160262C - Technique de liberation d'enzyme marqueur; methodes d'essai pour deceler la presence de proteases aspartiques et diverses activites enzymatiques hydrolytiques - Google Patents

Technique de liberation d'enzyme marqueur; methodes d'essai pour deceler la presence de proteases aspartiques et diverses activites enzymatiques hydrolytiques Download PDF

Info

Publication number: CA2160262C
Authority: CA; Canada
Prior art keywords: sample; solid support; indicator; reporter enzyme; hrpo
Prior art date: 1993-04-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002160262A

Other languages

English (en)

Other versions

CA2160262A1 (fr

Inventor

Paul J. Lawrence

Aulena Chaudhuri

Terrence J. Andreasen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Litmus Concepts Inc

Original Assignee

Litmus Concepts Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-14

Filing date

1994-04-13

Publication date

2002-03-26

1993-04-14 Priority claimed from US08/048,539 external-priority patent/US5418226A/en

1994-04-13 Application filed by Litmus Concepts Inc filed Critical Litmus Concepts Inc

1994-10-27 Publication of CA2160262A1 publication Critical patent/CA2160262A1/fr

2002-03-26 Application granted granted Critical

2002-03-26 Publication of CA2160262C publication Critical patent/CA2160262C/fr

2014-04-13 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

102000004190 Enzymes Human genes 0.000 title claims abstract description 287
108090000790 Enzymes Proteins 0.000 title claims abstract description 287
102000035101 Aspartic proteases Human genes 0.000 title claims abstract description 182
108091005502 Aspartic proteases Proteins 0.000 title claims abstract description 182
238000000034 method Methods 0.000 title claims abstract description 174
230000000694 effects Effects 0.000 title claims description 50
230000003301 hydrolyzing effect Effects 0.000 title abstract description 19
238000005516 engineering process Methods 0.000 title description 7
239000007787 solid Substances 0.000 claims abstract description 245
102000004157 Hydrolases Human genes 0.000 claims abstract description 168
108090000604 Hydrolases Proteins 0.000 claims abstract description 168
238000012360 testing method Methods 0.000 claims abstract description 159
230000008859 change Effects 0.000 claims abstract description 123
241000222122 Candida albicans Species 0.000 claims abstract description 120
230000009471 action Effects 0.000 claims abstract description 68
206010007134 Candida infections Diseases 0.000 claims abstract description 56
201000003984 candidiasis Diseases 0.000 claims abstract description 56
108010001336 Horseradish Peroxidase Proteins 0.000 claims description 189
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 124
241000147041 Guaiacum officinale Species 0.000 claims description 113
229940091561 guaiac Drugs 0.000 claims description 113
239000000463 material Substances 0.000 claims description 80
108010076119 Caseins Proteins 0.000 claims description 61
102000011632 Caseins Human genes 0.000 claims description 61
-1 or their derivatives Polymers 0.000 claims description 57
102000035195 Peptidases Human genes 0.000 claims description 50
108091005804 Peptidases Proteins 0.000 claims description 50
108010062374 Myoglobin Proteins 0.000 claims description 45
230000015572 biosynthetic process Effects 0.000 claims description 45
102000001554 Hemoglobins Human genes 0.000 claims description 38
108010054147 Hemoglobins Proteins 0.000 claims description 38
239000004365 Protease Substances 0.000 claims description 35
101710097834 Thiol protease Proteins 0.000 claims description 33
230000000007 visual effect Effects 0.000 claims description 33
235000021246 κ-casein Nutrition 0.000 claims description 33
235000018102 proteins Nutrition 0.000 claims description 32
102000004169 proteins and genes Human genes 0.000 claims description 32
108090000623 proteins and genes Proteins 0.000 claims description 32
239000000758 substrate Substances 0.000 claims description 31
ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 30
239000011324 bead Substances 0.000 claims description 30
239000011347 resin Substances 0.000 claims description 27
229920005989 resin Polymers 0.000 claims description 27
229920002101 Chitin Polymers 0.000 claims description 26
239000005018 casein Substances 0.000 claims description 25
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 24
235000021240 caseins Nutrition 0.000 claims description 24
239000001913 cellulose Substances 0.000 claims description 22
229920002678 cellulose Polymers 0.000 claims description 22
108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 18
102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 18
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 17
241000224527 Trichomonas vaginalis Species 0.000 claims description 17
239000011159 matrix material Substances 0.000 claims description 17
RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 16
102000003992 Peroxidases Human genes 0.000 claims description 16
102000008186 Collagen Human genes 0.000 claims description 15
108010035532 Collagen Proteins 0.000 claims description 15
102000016942 Elastin Human genes 0.000 claims description 15
108010014258 Elastin Proteins 0.000 claims description 15
102000011782 Keratins Human genes 0.000 claims description 15
108010076876 Keratins Proteins 0.000 claims description 15
229920001436 collagen Polymers 0.000 claims description 15
229920002549 elastin Polymers 0.000 claims description 15
102000004316 Oxidoreductases Human genes 0.000 claims description 14
108090000854 Oxidoreductases Proteins 0.000 claims description 14
229920000058 polyacrylate Polymers 0.000 claims description 14
241000283690 Bos taurus Species 0.000 claims description 13
230000001580 bacterial effect Effects 0.000 claims description 13
MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 claims description 12
108010013639 Peptidoglycan Proteins 0.000 claims description 12
210000002421 cell wall Anatomy 0.000 claims description 12
239000000499 gel Substances 0.000 claims description 12
229920002401 polyacrylamide Polymers 0.000 claims description 12
229920000515 polycarbonate Polymers 0.000 claims description 12
239000004417 polycarbonate Substances 0.000 claims description 12
229920000139 polyethylene terephthalate Polymers 0.000 claims description 12
239000000843 powder Substances 0.000 claims description 12
239000004677 Nylon Substances 0.000 claims description 11
108010022999 Serine Proteases Proteins 0.000 claims description 11
229920002472 Starch Polymers 0.000 claims description 11
239000012634 fragment Substances 0.000 claims description 11
229920001778 nylon Polymers 0.000 claims description 11
235000019698 starch Nutrition 0.000 claims description 11
239000008107 starch Substances 0.000 claims description 11
229920000936 Agarose Polymers 0.000 claims description 10
102000012479 Serine Proteases Human genes 0.000 claims description 10
YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 9
108091005658 Basic proteases Proteins 0.000 claims description 9
102000016938 Catalase Human genes 0.000 claims description 9
108010053835 Catalase Proteins 0.000 claims description 9
102000053187 Glucuronidase Human genes 0.000 claims description 9
108010060309 Glucuronidase Proteins 0.000 claims description 9
108090000769 Isomerases Proteins 0.000 claims description 9
102000004195 Isomerases Human genes 0.000 claims description 9
102000004357 Transferases Human genes 0.000 claims description 9
108090000992 Transferases Proteins 0.000 claims description 9
239000005289 controlled pore glass Substances 0.000 claims description 9
108090000765 processed proteins & peptides Proteins 0.000 claims description 9
108091005508 Acid proteases Proteins 0.000 claims description 8
108010006035 Metalloproteases Proteins 0.000 claims description 8
102000001253 Protein Kinase Human genes 0.000 claims description 8
108060006633 protein kinase Proteins 0.000 claims description 8
102000005741 Metalloproteases Human genes 0.000 claims description 7
108040007629 peroxidase activity proteins Proteins 0.000 claims description 7
102000009027 Albumins Human genes 0.000 claims description 6
108010088751 Albumins Proteins 0.000 claims description 6
229920002307 Dextran Polymers 0.000 claims description 6
108010046334 Urease Proteins 0.000 claims description 6
230000004520 agglutination Effects 0.000 claims description 5
238000001556 precipitation Methods 0.000 claims description 5
108060003951 Immunoglobulin Proteins 0.000 claims description 4
108010041102 azocasein Proteins 0.000 claims description 4
HLVXFWDLRHCZEI-UHFFFAOYSA-N chromotropic acid Chemical compound OS(=O)(=O)C1=CC(O)=C2C(O)=CC(S(O)(=O)=O)=CC2=C1 HLVXFWDLRHCZEI-UHFFFAOYSA-N 0.000 claims description 4
102000018358 immunoglobulin Human genes 0.000 claims description 4
239000005020 polyethylene terephthalate Substances 0.000 claims description 4
HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 claims 1
101710088194 Dehydrogenase Proteins 0.000 claims 1
102100030856 Myoglobin Human genes 0.000 claims 1
239000003153 chemical reaction reagent Substances 0.000 abstract description 54
239000013626 chemical specie Substances 0.000 abstract description 17
239000013642 negative control Substances 0.000 abstract description 16
239000013641 positive control Substances 0.000 abstract description 16
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
201000010099 disease Diseases 0.000 abstract description 3
244000052769 pathogen Species 0.000 abstract description 2
230000001717 pathogenic effect Effects 0.000 abstract description 2
229940088598 enzyme Drugs 0.000 description 255
239000000523 sample Substances 0.000 description 177
239000000872 buffer Substances 0.000 description 95
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 91
239000000243 solution Substances 0.000 description 87
238000002360 preparation method Methods 0.000 description 74
229940095731 candida albicans Drugs 0.000 description 64
239000000725 suspension Substances 0.000 description 61
238000006243 chemical reaction Methods 0.000 description 50
229920002684 Sepharose Polymers 0.000 description 47
238000005119 centrifugation Methods 0.000 description 47
102000036675 Myoglobin Human genes 0.000 description 44
102000057297 Pepsin A Human genes 0.000 description 42
108090000284 Pepsin A Proteins 0.000 description 42
229940111202 pepsin Drugs 0.000 description 42
150000001299 aldehydes Chemical class 0.000 description 41
239000003112 inhibitor Substances 0.000 description 41
239000012530 fluid Substances 0.000 description 40
108091003079 Bovine Serum Albumin Proteins 0.000 description 38
229940098773 bovine serum albumin Drugs 0.000 description 38
239000012153 distilled water Substances 0.000 description 37
239000006228 supernatant Substances 0.000 description 37
239000007987 MES buffer Substances 0.000 description 36
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 34
238000003556 assay Methods 0.000 description 33
239000008351 acetate buffer Substances 0.000 description 30
239000003550 marker Substances 0.000 description 30
239000000203 mixture Substances 0.000 description 29
230000003647 oxidation Effects 0.000 description 27
238000007254 oxidation reaction Methods 0.000 description 27
241000228251 Aspergillus phoenicis Species 0.000 description 26
238000010168 coupling process Methods 0.000 description 26
239000010410 layer Substances 0.000 description 24
235000019833 protease Nutrition 0.000 description 24
239000007983 Tris buffer Substances 0.000 description 23
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 22
241000222120 Candida <Saccharomycetales> Species 0.000 description 21
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 21
238000011534 incubation Methods 0.000 description 19
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 16
238000002474 experimental method Methods 0.000 description 16
210000004027 cell Anatomy 0.000 description 15
238000000576 coating method Methods 0.000 description 15
239000001963 growth medium Substances 0.000 description 15
230000008878 coupling Effects 0.000 description 14
238000005859 coupling reaction Methods 0.000 description 14
239000004093 hydrolase inhibitor Substances 0.000 description 14
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 14
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 14
239000012085 test solution Substances 0.000 description 14
229940124036 Hydrolase inhibitor Drugs 0.000 description 13
239000002253 acid Substances 0.000 description 13
241000894007 species Species 0.000 description 13
239000000126 substance Substances 0.000 description 13
239000007788 liquid Substances 0.000 description 12
239000008057 potassium phosphate buffer Substances 0.000 description 12
239000007974 sodium acetate buffer Substances 0.000 description 12
240000003291 Armoracia rusticana Species 0.000 description 11
235000011330 Armoracia rusticana Nutrition 0.000 description 11
102000004142 Trypsin Human genes 0.000 description 11
108090000631 Trypsin Proteins 0.000 description 11
108010091212 pepstatin Proteins 0.000 description 11
FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 11
239000008363 phosphate buffer Substances 0.000 description 11
239000012588 trypsin Substances 0.000 description 11
108090001060 Lipase Proteins 0.000 description 10
102000004882 Lipase Human genes 0.000 description 10
239000004367 Lipase Substances 0.000 description 10
108090000526 Papain Proteins 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 10
235000019421 lipase Nutrition 0.000 description 10
229940055729 papain Drugs 0.000 description 10
235000019834 papain Nutrition 0.000 description 10
239000008188 pellet Substances 0.000 description 10
229950000964 pepstatin Drugs 0.000 description 10
239000007790 solid phase Substances 0.000 description 10
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 9
101710163270 Nuclease Proteins 0.000 description 9
108700020962 Peroxidase Proteins 0.000 description 9
102000005262 Sulfatase Human genes 0.000 description 9
230000007062 hydrolysis Effects 0.000 description 9
238000006460 hydrolysis reaction Methods 0.000 description 9
230000002779 inactivation Effects 0.000 description 9
150000003839 salts Chemical class 0.000 description 9
108060007951 sulfatase Proteins 0.000 description 9
108020005199 Dehydrogenases Proteins 0.000 description 8
108090000371 Esterases Proteins 0.000 description 8
241000203734 Mobiluncus curtisii Species 0.000 description 8
108010006232 Neuraminidase Proteins 0.000 description 8
102000005348 Neuraminidase Human genes 0.000 description 8
108091007187 Reductases Proteins 0.000 description 8
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 8
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 8
238000007796 conventional method Methods 0.000 description 8
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
238000011065 in-situ storage Methods 0.000 description 8
230000000415 inactivating effect Effects 0.000 description 8
239000000137 peptide hydrolase inhibitor Substances 0.000 description 8
239000002953 phosphate buffered saline Substances 0.000 description 8
102000004196 processed proteins & peptides Human genes 0.000 description 8
230000004044 response Effects 0.000 description 8
239000013049 sediment Substances 0.000 description 8
102000012286 Chitinases Human genes 0.000 description 7
108010022172 Chitinases Proteins 0.000 description 7
239000000427 antigen Substances 0.000 description 7
102000036639 antigens Human genes 0.000 description 7
108091007433 antigens Proteins 0.000 description 7
239000003696 aspartic proteinase inhibitor Substances 0.000 description 7
229910021538 borax Inorganic materials 0.000 description 7
150000002148 esters Chemical class 0.000 description 7
229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
229960001922 sodium perborate Drugs 0.000 description 7
235000010339 sodium tetraborate Nutrition 0.000 description 7
YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 7
239000013595 supernatant sample Substances 0.000 description 7
239000004094 surface-active agent Substances 0.000 description 7
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 7
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 6
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
RDFCSSHDJSZMTQ-ZDUSSCGKSA-N Tos-Lys-CH2Cl Chemical compound CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 RDFCSSHDJSZMTQ-ZDUSSCGKSA-N 0.000 description 6
238000007792 addition Methods 0.000 description 6
239000000853 adhesive Substances 0.000 description 6
230000001070 adhesive effect Effects 0.000 description 6
239000011248 coating agent Substances 0.000 description 6
238000001514 detection method Methods 0.000 description 6
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 6
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
229920003023 plastic Polymers 0.000 description 6
239000004033 plastic Substances 0.000 description 6
238000012546 transfer Methods 0.000 description 6
238000005406 washing Methods 0.000 description 6
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 5
UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 5
238000009835 boiling Methods 0.000 description 5
150000001720 carbohydrates Chemical class 0.000 description 5
235000014633 carbohydrates Nutrition 0.000 description 5
238000007373 indentation Methods 0.000 description 5
230000000977 initiatory effect Effects 0.000 description 5
150000002632 lipids Chemical class 0.000 description 5
150000007523 nucleic acids Chemical class 0.000 description 5
102000039446 nucleic acids Human genes 0.000 description 5
108020004707 nucleic acids Proteins 0.000 description 5
230000001105 regulatory effect Effects 0.000 description 5
239000002904 solvent Substances 0.000 description 5
241000228212 Aspergillus Species 0.000 description 4
108010059892 Cellulase Proteins 0.000 description 4
239000001856 Ethyl cellulose Substances 0.000 description 4
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
102000016943 Muramidase Human genes 0.000 description 4
108010014251 Muramidase Proteins 0.000 description 4
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
238000001994 activation Methods 0.000 description 4
239000003593 chromogenic compound Substances 0.000 description 4
235000014113 dietary fatty acids Nutrition 0.000 description 4
229920001249 ethyl cellulose Polymers 0.000 description 4
235000019325 ethyl cellulose Nutrition 0.000 description 4
239000000194 fatty acid Substances 0.000 description 4
229930195729 fatty acid Natural products 0.000 description 4
238000007478 fluorogenic assay Methods 0.000 description 4
239000008103 glucose Substances 0.000 description 4
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
238000002372 labelling Methods 0.000 description 4
238000009630 liquid culture Methods 0.000 description 4
239000003960 organic solvent Substances 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
230000000644 propagated effect Effects 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
235000017557 sodium bicarbonate Nutrition 0.000 description 4
229910000033 sodium borohydride Inorganic materials 0.000 description 4
239000012279 sodium borohydride Substances 0.000 description 4
239000001488 sodium phosphate Substances 0.000 description 4
229910000162 sodium phosphate Inorganic materials 0.000 description 4
VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 4
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
229920003176 water-insoluble polymer Polymers 0.000 description 4
229920003169 water-soluble polymer Polymers 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
229920002799 BoPET Polymers 0.000 description 3
239000005041 Mylar™ Substances 0.000 description 3
239000004698 Polyethylene Substances 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 3
230000004913 activation Effects 0.000 description 3
238000013019 agitation Methods 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
229940106157 cellulase Drugs 0.000 description 3
238000007398 colorimetric assay Methods 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
238000009792 diffusion process Methods 0.000 description 3
239000002532 enzyme inhibitor Substances 0.000 description 3
238000011049 filling Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
229940072221 immunoglobulins Drugs 0.000 description 3
YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 3
239000004325 lysozyme Substances 0.000 description 3
229960000274 lysozyme Drugs 0.000 description 3
235000010335 lysozyme Nutrition 0.000 description 3
229920000573 polyethylene Polymers 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
239000003001 serine protease inhibitor Substances 0.000 description 3
238000000638 solvent extraction Methods 0.000 description 3
150000003573 thiols Chemical class 0.000 description 3
229910052719 titanium Inorganic materials 0.000 description 3
239000010936 titanium Substances 0.000 description 3
238000010269 ABTS assay Methods 0.000 description 2
102000013142 Amylases Human genes 0.000 description 2
108010065511 Amylases Proteins 0.000 description 2
229940092160 Aspartic protease inhibitor Drugs 0.000 description 2
102100037328 Chitotriosidase-1 Human genes 0.000 description 2
229920004934 Dacron® Polymers 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
241000203736 Mobiluncus Species 0.000 description 2
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
239000012790 adhesive layer Substances 0.000 description 2
235000019418 amylase Nutrition 0.000 description 2
230000003466 anti-cipated effect Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
OVIFHFRAOKPVPC-UHFFFAOYSA-N aspartic protease inhibitor Natural products CC(N)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(O)=O)C(=O)NC(CC(O)=O)C(=O)NC(CC(O)=O)C(=O)NC(CC(O)=O)C(=O)N1CCCC1C(=O)N1C(C(=O)NC(CCC(O)=O)C(O)=O)CCC1 OVIFHFRAOKPVPC-UHFFFAOYSA-N 0.000 description 2
230000008901 benefit Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
239000002738 chelating agent Substances 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000013270 controlled release Methods 0.000 description 2
238000012258 culturing Methods 0.000 description 2
239000002852 cysteine proteinase inhibitor Substances 0.000 description 2
239000003599 detergent Substances 0.000 description 2
229940000406 drug candidate Drugs 0.000 description 2
239000003777 experimental drug Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
239000007999 glycylglycine buffer Substances 0.000 description 2
229960003878 haloperidol Drugs 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
239000002609 medium Substances 0.000 description 2
239000003475 metalloproteinase inhibitor Substances 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
230000005012 migration Effects 0.000 description 2
108010000416 ovomacroglobulin Proteins 0.000 description 2
JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
239000000575 pesticide Substances 0.000 description 2
239000011148 porous material Substances 0.000 description 2
235000019419 proteases Nutrition 0.000 description 2
238000011160 research Methods 0.000 description 2
238000007789 sealing Methods 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000011343 solid material Substances 0.000 description 2
238000007711 solidification Methods 0.000 description 2
230000008023 solidification Effects 0.000 description 2
230000007704 transition Effects 0.000 description 2
239000012780 transparent material Substances 0.000 description 2
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
238000009736 wetting Methods 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
PCDWFBFHIIKIPM-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-2-sulfonic acid Chemical compound C1=CC=C2N(CC)C(S(O)(=O)=O)SC2=C1 PCDWFBFHIIKIPM-UHFFFAOYSA-N 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
240000006432 Carica papaya Species 0.000 description 1
235000009467 Carica papaya Nutrition 0.000 description 1
101710151413 Chitinase 1 Proteins 0.000 description 1
101710132290 Chitotriosidase-1 Proteins 0.000 description 1
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
101710107327 Endochitinase 1 Proteins 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
229920004142 LEXAN™ Polymers 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
239000004418 Lexan Substances 0.000 description 1
101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 1
208000007027 Oral Candidiasis Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
229940122618 Trypsin inhibitor Drugs 0.000 description 1
101710162629 Trypsin inhibitor Proteins 0.000 description 1
206010046443 Urethral discharge Diseases 0.000 description 1
UYFXJSBYTIMJAH-UHFFFAOYSA-J [Ti+4].[O-]O.[O-]O.[O-]O.[O-]O Chemical compound [Ti+4].[O-]O.[O-]O.[O-]O.[O-]O UYFXJSBYTIMJAH-UHFFFAOYSA-J 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000012615 aggregate Substances 0.000 description 1
150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical class C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
239000002812 cholic acid derivative Substances 0.000 description 1
230000001427 coherent effect Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000002131 composite material Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000000385 dialysis solution Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
210000000416 exudates and transudate Anatomy 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
150000002194 fatty esters Chemical class 0.000 description 1
235000003891 ferrous sulphate Nutrition 0.000 description 1
239000011790 ferrous sulphate Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000008098 formaldehyde solution Substances 0.000 description 1
239000003517 fume Substances 0.000 description 1
229930182478 glucoside Natural products 0.000 description 1
239000008187 granular material Substances 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
150000002432 hydroperoxides Chemical class 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
238000010324 immunological assay Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000010030 laminating Methods 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000010808 liquid waste Substances 0.000 description 1
229920001684 low density polyethylene Polymers 0.000 description 1
239000004702 low-density polyethylene Substances 0.000 description 1
238000003760 magnetic stirring Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
ZVEZMVFBMOOHAT-UHFFFAOYSA-N nonane-1-thiol Chemical compound CCCCCCCCCS ZVEZMVFBMOOHAT-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000007639 printing Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000007065 protein hydrolysis Effects 0.000 description 1
230000029865 regulation of blood pressure Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000010076 replication Effects 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000007790 scraping Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000002002 slurry Substances 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000003774 sulfhydryl reagent Substances 0.000 description 1
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
230000009182 swimming Effects 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000012549 training Methods 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
238000013022 venting Methods 0.000 description 1
230000007923 virulence factor Effects 0.000 description 1
239000000304 virulence factor Substances 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000011800 void material Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
- G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

CA002160262A 1993-04-14 1994-04-13 Technique de liberation d'enzyme marqueur; methodes d'essai pour deceler la presence de proteases aspartiques et diverses activites enzymatiques hydrolytiques Expired - Fee Related CA2160262C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/048,539 US5418226A (en)	1992-04-22	1993-04-14	Monoquaternary 2,16-bispiperidinylandrostane derivatives
US08/048,536		1993-04-14
PCT/US1994/004098 WO1994024306A1 (fr)	1993-04-14	1994-04-13	Technologie de liberation d'enzyme rapporteur: procedes de detection de la presence de proteases aspartiques et d'autres activites d'enzymes hydrolytiques

Publications (2)

Publication Number	Publication Date
CA2160262A1 CA2160262A1 (fr)	1994-10-27
CA2160262C true CA2160262C (fr)	2002-03-26

Family

ID=21955126

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002160262A Expired - Fee Related CA2160262C (fr)	1993-04-14	1994-04-13	Technique de liberation d'enzyme marqueur; methodes d'essai pour deceler la presence de proteases aspartiques et diverses activites enzymatiques hydrolytiques

Country Status (8)

Country	Link
JP (1)	JP3705441B2 (fr)
AU (1)	AU6633894A (fr)
BR (1)	BR9405963A (fr)
CA (1)	CA2160262C (fr)
CZ (1)	CZ289902B6 (fr)
HU (1)	HUT73393A (fr)
PL (1)	PL180526B1 (fr)
WO (1)	WO1994024306A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5571684A (en) *	1994-11-07	1996-11-05	Litmus Concepts, Inc.	Assay for proline iminopeptidase and other hydrolytic activities
CA2202993C (fr) *	1994-11-07	2002-01-01	Paul J. Lawrence	Test pour la proline iminopeptidase et pour d'autres activites hydrolytiques
GB0111987D0 (en) *	2001-05-16	2001-07-04	Univ Sheffield	Method
JP2005528887A (ja)	2002-01-31	2005-09-29	エクスプレッシブコンストラクツ，インコーポレイテッド	微生物の検出方法
JP2009501715A (ja) *	2005-07-13	2009-01-22	イーシーアイバイオテックインコーポレイティッド	女性の状態を評価するための基質、センサー、および方法
US7878644B2 (en)	2005-11-16	2011-02-01	Gerber Scientific International, Inc.	Light cure of cationic ink on acidic substrates
EP2044211A2 (fr) *	2006-06-09	2009-04-08	Bio Pur AG	Procédé de détection des réactions enzymatiques
AT509355B1 (de) *	2010-02-10	2012-04-15	Univ Graz Tech	Testanordnung
CN116970479B (zh) *	2023-09-25	2023-12-19	哈尔滨瀚邦医疗科技有限公司	一种胃蛋白酶测定试剂盒及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4859581A (en) *	1986-03-10	1989-08-22	Board Of Regents, The University Of Texas System	Endoglycosidase assay
US4789629A (en) *	1986-11-24	1988-12-06	Smithkline Beckman Corporation	Method and device for collecting and testing for fecal occult blood
DE4217474A1 (de) *	1992-05-27	1993-12-02	Boehringer Mannheim Gmbh	Verfahren und Mittel zur Bestimmung eines Analyts

1994
- 1994-04-13 JP JP52344194A patent/JP3705441B2/ja not_active Expired - Fee Related
- 1994-04-13 AU AU66338/94A patent/AU6633894A/en not_active Abandoned
- 1994-04-13 WO PCT/US1994/004098 patent/WO1994024306A1/fr not_active Ceased
- 1994-04-13 BR BR9405963A patent/BR9405963A/pt active Search and Examination
- 1994-04-13 CA CA002160262A patent/CA2160262C/fr not_active Expired - Fee Related
- 1994-04-13 PL PL94311140A patent/PL180526B1/pl not_active IP Right Cessation
- 1994-04-13 CZ CZ19952664A patent/CZ289902B6/cs not_active IP Right Cessation
- 1994-04-13 HU HU9502965A patent/HUT73393A/hu unknown

Also Published As

Publication number	Publication date
JP3705441B2 (ja)	2005-10-12
CA2160262A1 (fr)	1994-10-27
AU6633894A (en)	1994-11-08
HUT73393A (en)	1996-07-29
CZ266495A3 (en)	1996-05-15
BR9405963A (pt)	1996-01-30
PL180526B1 (pl)	2001-02-28
HU9502965D0 (en)	1995-12-28
CZ289902B6 (cs)	2002-04-17
JPH08509124A (ja)	1996-10-01
PL311140A1 (en)	1996-02-05
WO1994024306A1 (fr)	1994-10-27

Legal Events

Date	Code	Title	Description
1998-02-13	EEER	Examination request
2011-04-13	MKLA	Lapsed

Publication	Publication Date	Title
EP0694077B1 (fr)	2000-05-24	Technologie de liberation d'enzyme rapporteur: procedes de detection de la presence de proteases aspartiques et d'autres activites d'enzymes hydrolytiques
US5571684A (en)	1996-11-05	Assay for proline iminopeptidase and other hydrolytic activities
US7504235B2 (en)	2009-03-17	Enzyme detection technique
US4681841A (en)	1987-07-21	Enzymatic assay method
CA2160262C (fr)	2002-03-26	Technique de liberation d'enzyme marqueur; methodes d'essai pour deceler la presence de proteases aspartiques et diverses activites enzymatiques hydrolytiques
CA2198951C (fr)	2003-07-22	Methode pour fournir un point final de reaction pour des methodes de detection enzymatiques
AU754237B2 (en)	2002-11-07	Uric acid assay device with stabilized uricase reagent composition
AU721069B2 (en)	2000-06-22	Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities
US6750033B2 (en)	2004-06-15	Positive response biosensors and other sensors
EP0244825B1 (fr)	1992-10-07	Elément sec pour l'analyse du cholestérol
CA2202993C (fr)	2002-01-01	Test pour la proline iminopeptidase et pour d'autres activites hydrolytiques
AU2002303565A1 (en)	2003-05-01	Positive response biosensors and other sensors
GB1590738A (en)	1981-06-10	Analytical element
USRE33635E (en)	1991-07-09	Enzymatic assay method
JP2000035427A (ja)	2000-02-02	乾式分析要素の製造方法及び乾式分析要素
JPH0522520B2 (fr)	1993-03-29